Min Ju Kim

Min Ju Kim

Auto-generated profile, based on publicly available information

Min Ju Kim

Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
ELEun Sun Lee
Eun Sun Lee
MKMin Ju Kim
Min Ju Kim
SPSung Chan Park
Sung Chan Park
BHBo Yun Hur
Bo Yun Hur
JHJong Hee Hyun
Jong Hee Hyun
JOJae Hwan Oh
Jae Hwan Oh

1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SPSeong Ho Park
Seong Ho Park
SCSeung Hyun Cho
Seung Hyun Cho
SCSang Hyun Choi
Sang Hyun Choi
JJJong Keon Jang
Jong Keon Jang
MKMin Ju Kim
Min Ju Kim
TCthe Korean Society of Abdominal Radiology Study Group for Rectal Cancer
the Korean Society of Abdominal Radiology Study Group for Rectal Cancer
Park SH, et al. Korean J Radiol. 2020 Jul;21(7):812-828. https://doi.org/10.3348/kjr.2020.0483

1 January 2015 in Journal of the Korean Medical Association
Verified
Journal Article
Open access
PDF file
DSDae Kyung Sohn
Dae Kyung Sohn
MKMin Ju Kim
Min Ju Kim
YPYounhee Park
Younhee Park
MSMinah Suh
Minah Suh
ASAesun Shin
Aesun Shin
SJSeung-Yong Jeong
Seung-Yong Jeong
Sohn DK, et al. J Korean Med Assoc. 2015 May;58(5):420-432. http://dx.doi.org/10.5124/jkma.2015.58.5.420

17 December 2019 in IEEE Access
Verified
Journal Article
Open access
JLJoohyung Lee
Joohyung Lee
JOJi Eun Oh
Ji Eun Oh
MKMin Ju Kim
Min Ju Kim
BHBo Yun Hur
Bo Yun Hur
DSDae Kyung Sohn
Dae Kyung Sohn
In preoperative imaging, the demarcation of rectal cancer with magnetic resonance images provides an important basis for cancer staging and treatment planning. Recently, deep learning has greatly improved the state-of-the-art method in automatic segmentation. However, limitations in data availability in the medical field can cause large variance and consequent overfitting to medical image segmentation networks. In this study, we propose methods to reduce the model variance of a rectal cancer segmentation network by adding a rectum segmentation task and performing data augmentation; the geometric correlation between the rectum and rectal cancer motivated the former approach. Moreover, we propose a method to perform a bias-variance analysis within an arbitrary region-of-interest (ROI) of a segmentation network, which we applied to assess the efficacy of our approaches in reducing model variance. As a result, adding a rectum segmentation task reduced the model variance of the rectal cancer segmentation network within tumor regions by a factor of 0.90; data augmentation further reduced the variance by a factor of 0.89. These approaches also reduced the training duration by a factor of 0.96 and a further factor of 0.78, respectively. Our approaches will improve the quality of rectal cancer staging by increasing the accuracy of its automatic demarcation and by providing rectum boundary information since rectal cancer staging requires the demarcation of both rectum and rectal cancer. Besides such clinical benefits, our method also enables segmentation networks to be assessed with bias-variance analysis within an arbitrary ROI, such as a cancerous region.

1 December 2018 in Journal of Surgical Research
Verified
Journal Article
Closed access
BPByung Kwan Park
Byung Kwan Park
SLSang Jae Lee
Sang Jae Lee
BHBo Yun Hur
Bo Yun Hur
MKMin Ju Kim
Min Ju Kim
SPSung Chan Park
Sung Chan Park
JOJae Hwan Oh
Jae Hwan Oh

4 November 2013 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
SLSung Uk Lee
Sung Uk Lee
DKDae Yong Kim
Dae Yong Kim
Sun-Young KimSun-Young Kim
Sun-Young Kim
JBJi Yeon Baek
Ji Yeon Baek
HCHee Jin Chang
Hee Jin Chang
JOJae Hwan Oh
Jae Hwan Oh
Background: To compare the short-term tumor response and long-term clinical outcome of two preoperative chemoradiotherapy (CRT) regimens for locally advanced rectal cancer. Methods: This study included 231 patients scheduled for preoperative CRT using two chemotherapeutic protocols from April 2003–August 2006. Pelvic radiotherapy (50.4 Gy) was delivered concurrently with capecitabine (n = 148) or capecitabine/irinotecan (n = 83). Surgery was performed 4–8 weeks after CRT completion. Tumor responses to CRT were assessed using both radiologic and pathologic measurements. Radiologic responses were evaluated by magnetic resonance volumetry, which was performed at the initial work-up and after completion of preoperative CRT just before surgery. Pathologic responses were assessed with downstaging (ypStage 0-1) and grading tumor regression. Clinical outcomes were evaluated in terms of local control, relapse-free survival, and overall survival rates. Results: Radiologic examination demonstrated that tumor volume decreased by 65.6% in the capecitabine group and 66.8% capecitabine/irinotecan group (p = 0.731). Postoperative pathologic stage determination showed that tumor downstaging occurred in 44.1% of the capecitabine group and 48.6% of the capecitabine/irinotecan group (p = 0.538). The sum of tumor regression grade 3 (near complete response) and 4 (complete response) after CRT were 28.6% in the capecitabine group and 37.5% in the capecitabine/irinotecan group (p = 0.247). There were no significant differences between the two groups in 5-year local control (91.7% vs. 92.5%; p = 0.875), relapse-free survival (80.8% vs. 77.2%; p = 0.685), and overall survival (88.4% vs. 90.4%; p = 0.723). Conclusions: This study revealed no differences in the short-term tumor response and long-term clinical outcome between preoperative capecitabine and capecitabine/irinotecan CRT regimens for locally advanced rectal cancer.